• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S100P是用于诊断和预测脓毒症预后的核心基因。

S100P is a core gene for diagnosing and predicting the prognosis of sepsis.

作者信息

Shen Yu Zhou, Li Hai Li, Hu Ying Chun

机构信息

Department of Emergency Medicine, The Affiliated Hospital of Southwest Medical University, No. 25, Taiping Road, Sichuan, Lu Zhou, People's Republic of China.

出版信息

Sci Rep. 2025 Feb 25;15(1):6718. doi: 10.1038/s41598-025-90858-8.

DOI:10.1038/s41598-025-90858-8
PMID:40000745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11861684/
Abstract

Sepsis, characterized as a severe systemic inflammatory response syndrome, typically originates from an exaggerated immune response to infection that gives rise to organ dysfunction. Serving as one of the predominant causes of death among critically ill patients, it's pressing to acquire an in-depth understanding of its intricate pathological mechanisms to strengthen diagnostic and therapeutic strategies. By integrating genomic, transcriptomic, proteomic, and metabolomic data across multiple biological levels, multi-omics research analysis has emerged as a crucial tool for unveiling the complex interactions within biological systems and unraveling disease mechanisms in recent years. Samples were collected from 23 cases of sepsis patients and 10 healthy volunteers from January 2019 to December 2020. The protein components in the samples were explored by independent data acquisition (DIA) analysis method, while Circular RNA (circRNA) categories were usually identified by RNA sequencing (RNA-seq) technology. Subsequent to the above steps, data quality monitoring was performed by employing software, and unqualified sequences were excluded, and conditions were set for differential expression network analysis (protein group and circRNA group were separately used log |FC|≥ 1 and log |FC|≥ 2, P < 0.050). Gene Ontology (GO) enrichment analysis and gene set enrichment analysis (GSEA) analysis were performed on common differentially expressed proteins, followed by protein-protein interaction between common differentially expressed genes and cytoscape software enrichment analysis, and subsequently its association with associated diseases (Disease Ontology (DO)) was investigated in an all-round manner. Afterwards, the distribution distinction of common differentially expressed genes in sepsis group and healthy volunteer group was displayed by heat map after Meta-analysis. Subsequent to the above procedures, pivotal targets with noticeable survival curve distinctions in two states were screened out after Meta-analysis. At last, their potential value was verified by in vitro cell experiment, which provided reference for further discussion of the diagnostic value and prognostic effect of target gene. A total of 174 DEPs and 308 DEcircRNAs were identified in the proteomics analysis, while a total of 12 common differentially expressed genes were identified after joint analysis. The protein-protein interaction (PPI) network suggested the degree of interaction between the dissimilar genes, and the heat map demonstrated their specific distribution in distinct groups. Through enrichment analysis, these proteins predominantly participated in a sequence of crucial processes such as intracellular material synthesis and secretion, changes in inflammatory receptors and immune inflammatory response. The meta-analysis identified that S100P is highly expressed in sepsis. As illustrated by the ROC curve, this gene has high clinical diagnostic value, and utimately confirmed its expression in sepsis through in vitro cell experiments. In these two groups of healthy people and septic patients, S100P demonstrated a more obvious trend of differential expression; Cell experiments also proved its value in diagnosis and prognosis judgment in sepsis; As a result, they may become diagnostic and prognostic markers for sepsis in clinical practice.

摘要

脓毒症,其特征为严重的全身炎症反应综合征,通常源于对感染的过度免疫反应,进而导致器官功能障碍。作为重症患者主要的死亡原因之一,深入了解其复杂的病理机制对于加强诊断和治疗策略至关重要。近年来,通过整合多个生物学层面的基因组、转录组、蛋白质组和代谢组数据,多组学研究分析已成为揭示生物系统内复杂相互作用及阐明疾病机制的关键工具。在2019年1月至2020年12月期间,从23例脓毒症患者和10名健康志愿者中采集样本。样本中的蛋白质成分通过独立数据采集(DIA)分析方法进行探究,而环状RNA(circRNA)类别通常通过RNA测序(RNA-seq)技术进行鉴定。在上述步骤之后,使用软件进行数据质量监测,排除不合格序列,并设定差异表达网络分析的条件(蛋白质组和circRNA组分别使用log |FC|≥1和log |FC|≥2,P < 0.050)。对共同差异表达的蛋白质进行基因本体(GO)富集分析和基因集富集分析(GSEA)分析,随后对共同差异表达基因之间的蛋白质-蛋白质相互作用以及细胞图谱软件进行富集分析,并全面研究其与相关疾病(疾病本体(DO))的关联。之后,通过Meta分析后用热图展示脓毒症组和健康志愿者组中共同差异表达基因的分布差异。在上述程序之后,通过Meta分析筛选出在两种状态下具有明显生存曲线差异的关键靶点。最后,通过体外细胞实验验证其潜在价值,为进一步探讨靶基因的诊断价值和预后效果提供参考。在蛋白质组学分析中总共鉴定出174个差异表达蛋白质(DEP)和308个差异表达环状RNA(DEcircRNA),而联合分析后总共鉴定出12个共同差异表达基因。蛋白质-蛋白质相互作用(PPI)网络表明不同基因之间的相互作用程度,热图展示了它们在不同组中的具体分布。通过富集分析,这些蛋白质主要参与一系列关键过程,如细胞内物质合成与分泌、炎症受体变化和免疫炎症反应。Meta分析确定S100P在脓毒症中高表达。如ROC曲线所示,该基因具有较高的临床诊断价值,并最终通过体外细胞实验证实其在脓毒症中的表达。在这两组健康人和脓毒症患者中,S100P表现出更明显的差异表达趋势;细胞实验也证明了其在脓毒症诊断和预后判断中的价值;因此,它们可能成为临床实践中脓毒症的诊断和预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/56abdd6a20e7/41598_2025_90858_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/c067d0c8046a/41598_2025_90858_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/d431c6199780/41598_2025_90858_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/abb4fb67a7b5/41598_2025_90858_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/f37f46d6b496/41598_2025_90858_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/5ac98fdd9cc5/41598_2025_90858_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/eb5a1b3b72e6/41598_2025_90858_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/f401a0fe359e/41598_2025_90858_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/1e99651668f9/41598_2025_90858_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/00eb71d8d8f2/41598_2025_90858_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/56abdd6a20e7/41598_2025_90858_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/c067d0c8046a/41598_2025_90858_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/d431c6199780/41598_2025_90858_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/abb4fb67a7b5/41598_2025_90858_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/f37f46d6b496/41598_2025_90858_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/5ac98fdd9cc5/41598_2025_90858_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/eb5a1b3b72e6/41598_2025_90858_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/f401a0fe359e/41598_2025_90858_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/1e99651668f9/41598_2025_90858_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/00eb71d8d8f2/41598_2025_90858_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad16/11861684/56abdd6a20e7/41598_2025_90858_Fig10_HTML.jpg

相似文献

1
S100P is a core gene for diagnosing and predicting the prognosis of sepsis.S100P是用于诊断和预测脓毒症预后的核心基因。
Sci Rep. 2025 Feb 25;15(1):6718. doi: 10.1038/s41598-025-90858-8.
2
CTSO and HLA-DQA1 as biomarkers in sepsis-associated ARDS: insights from RNA sequencing and immune infiltration analysis.CTSO和HLA - DQA1作为脓毒症相关急性呼吸窘迫综合征的生物标志物:来自RNA测序和免疫浸润分析的见解
BMC Infect Dis. 2025 Mar 7;25(1):326. doi: 10.1186/s12879-025-10726-8.
3
SPP1 is a plasma biomarker associated with the dia gnosis and prediction of prognosis in sepsis.SPP1 是一种与脓毒症诊断和预后预测相关的血浆生物标志物。
Sci Rep. 2024 Nov 8;14(1):27205. doi: 10.1038/s41598-024-78420-4.
4
Exploring the prognostic and diagnostic value of lactylation-related genes in sepsis.探讨乳酰化相关基因在脓毒症中的预后和诊断价值。
Sci Rep. 2024 Oct 4;14(1):23130. doi: 10.1038/s41598-024-74040-0.
5
Identification of sepsis-associated mitochondrial genes through RNA and single-cell sequencing approaches.通过RNA和单细胞测序方法鉴定脓毒症相关的线粒体基因。
BMC Med Genomics. 2024 May 3;17(1):120. doi: 10.1186/s12920-024-01891-x.
6
Proteomics Combined with RNA Sequencing to Screen Biomarkers of Sepsis.蛋白质组学联合RNA测序筛选脓毒症生物标志物
Infect Drug Resist. 2022 Sep 21;15:5575-5587. doi: 10.2147/IDR.S380137. eCollection 2022.
7
Identification of prognostic biomarkers of sepsis and construction of ceRNA regulatory networks.脓毒症预后生物标志物的鉴定及ceRNA调控网络的构建
Sci Rep. 2025 Jan 22;15(1):2850. doi: 10.1038/s41598-024-78502-3.
8
[Exploration of key ferroptosis-related genes as therapeutic targets for sepsis based on bioinformatics and the depiction of their immune profiles characterization].基于生物信息学探索关键铁死亡相关基因作为脓毒症的治疗靶点及其免疫图谱特征描述
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Oct;36(10):1025-1032. doi: 10.3760/cma.j.cn121430-20240524-00457.
9
[The role of transferrin receptor CD71 as a diagnostic and prognostic biomarker in sepsis].[转铁蛋白受体CD71作为脓毒症诊断和预后生物标志物的作用]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Feb;34(2):121-126. doi: 10.3760/cma.j.cn121430-20210617-00907.
10
Screening of key genes related to the prognosis of mouse sepsis.筛选与小鼠脓毒症预后相关的关键基因。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20202649.

本文引用的文献

1
S100A11 is a potential prognostic biomarker and correlated with tumor immunosuppressive microenvironment in glioma.S100A11是一种潜在的预后生物标志物,与胶质瘤中的肿瘤免疫抑制微环境相关。
Medicine (Baltimore). 2024 Dec 20;103(51):e40701. doi: 10.1097/MD.0000000000040701.
2
An overview of S100 proteins and their functions in skin homeostasis, interface dermatitis conditions and other skin pathologies.S100 蛋白概述及其在皮肤稳态、界面性皮炎和其他皮肤病理学中的功能。
Exp Dermatol. 2024 Aug;33(8):e15158. doi: 10.1111/exd.15158.
3
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma.
GSTO1 通过使 NPM1 去谷胱甘肽化来加重肺腺癌中 EGFR-TKIs 的耐药性和肿瘤转移。
Oncogene. 2024 Aug;43(33):2504-2516. doi: 10.1038/s41388-024-03096-z. Epub 2024 Jul 5.
4
CSRP1 gene: a potential novel prognostic marker in acute myeloid leukemia with implications for immune response.CSRP1基因:急性髓系白血病中一种潜在的新型预后标志物及其对免疫反应的影响
Discov Oncol. 2024 Jun 27;15(1):248. doi: 10.1007/s12672-024-01088-9.
5
Endogenous S100P-mediated autophagy regulates the chemosensitivity of leukemia cells through the p53/AMPK/mTOR pathway.内源性S100P介导的自噬通过p53/AMPK/mTOR途径调节白血病细胞的化学敏感性。
Am J Cancer Res. 2024 Mar 15;14(3):1121-1138. doi: 10.62347/NWXE8730. eCollection 2024.
6
VGLUT2 and APP family: unraveling the neurobiochemical mechanisms of neurostimulation therapy to STZ-induced diabetes and neuropathy.VGLUT2 和 APP 家族:揭开神经刺激疗法对 STZ 诱导的糖尿病和神经病变的神经生化机制。
Front Endocrinol (Lausanne). 2024 Feb 2;15:1336854. doi: 10.3389/fendo.2024.1336854. eCollection 2024.
7
Role of LCN2 in a murine model of hindlimb ischemia and in peripheral artery disease patients, and its potential regulation by miR-138-5P.LCN2 在小鼠后肢缺血模型和外周动脉疾病患者中的作用及其受 miR-138-5P 的潜在调控。
Atherosclerosis. 2023 Nov;385:117343. doi: 10.1016/j.atherosclerosis.2023.117343. Epub 2023 Oct 11.
8
ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.ORM1 通过 CALR 介导线粒体凋亡促进肾透明细胞肾细胞癌 (KIRC) 的肿瘤进展。
Sci Rep. 2023 Sep 21;13(1):15687. doi: 10.1038/s41598-023-42962-w.
9
Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78.肿瘤细胞中异常的 LYZ 表达可作为 HCC 的潜在生物标志物和靶点,并通过 csGRP78 促进肿瘤进展。
Proc Natl Acad Sci U S A. 2023 Jul 18;120(29):e2215744120. doi: 10.1073/pnas.2215744120. Epub 2023 Jul 10.
10
How can platelet proteomics best be used to interrogate disease?血小板蛋白质组学如何最好地用于探究疾病?
Platelets. 2023 Dec;34(1):2220046. doi: 10.1080/09537104.2023.2220046.